Pan-cancer differentially methylated regions are promising biomarkers…
A blood test identifying shared cancer methylation patterns achieved 97% specificity, advancing toward a single screening tool for multiple cancer types.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Oncolytic viruses and cytokine-based gene therapies reprogram the…
Combining oncolytic viruses with immune therapies shows promise for reawakening suppressed anti-tumor immunity in difficult-to-treat cancers.
Promising but preliminaryMultiselective Recognition of Metal Ion-Nucleic Acid Complexes by…
A novel blood test detects breast cancer mutations with near-perfect accuracy, potentially enabling faster staging through routine plasma samples.
Near-term implementable findingDeep learning for predicting pituitary neuroendocrine tumour lineage…
AI analysis of routine tumor slides predicts pituitary cancer subtypes with high accuracy, revealing immune patterns linked to recurrence.
Promising but preliminaryLongitudinal localization of leukaemic stem cells between the…
Blocking a protein that shelters leukemia stem cells makes them vulnerable to chemotherapy, leveraging an existing drug class.